Vaccination in rheumatic disease patients: results of a pilot quality improvement program

Figueroa Parra, Gabriel y Moreno Salinas, Andrea y Santoyo Fexas, Leticia y Gamboa Alonso, Carmen Magdalena y Carrizales Luna, Juan Pablo y Hernández Galarza, Ivan de Jesús y Galarza Delgado, Dionicio Ángel y Esquivel Valerio, Jorge Antonio (2022) Vaccination in rheumatic disease patients: results of a pilot quality improvement program. Rheumatology, 59 (6). pp. 362-366. ISSN 2084-9834

Vista previa

Texto
27830.pdf - Versión Publicada
Available under License Creative Commons Attribution Non-commercial No Derivatives.
Download (133kB) | Vista previa

URL o página oficial: https://reu.termedia.pl/Vaccination-in-rheumatic-d...

Resumen

Objectives: Patients with rheumatic diseases (RD) are at increased risk of infections. Vaccination is recognized as a successful public health measure and is recommended for RD patients. The aim of this study was to describe the strategies implemented in an academic rheumatology outpatient clinic as part of a fellow-in-training-led vaccination quality improvement (QI) program and to explore the vaccination uptake before and one year after the implementation. Material and methods: The program’s objective is the promotion of vaccination among patients and rheumatology fellows (by educational interventions, development of vaccination charts and orders, and modifications to electronic medical records to register vaccination dates and generate reminders). As part of the continuous evaluation of the QI program, a descriptive cross-sectional study was performed to evaluate vaccine uptake pre- and post-interventions and vaccination barriers one year after implementation. Consecutive patients with RD answered a self-administered questionnaire. Results are shown as descriptive statistics. Results: Before the program started 73 patients were surveyed and 102 patients one year after. The vaccination uptake rates for influenza pre- and post-interventions were 43% and 55%; for pneumococcal vaccination they were 26% and 30%; for herpes zoster they were 0% and 4%; for human papillomavirus they were 4% and 10%; for hepatitis B (HBV) they were 19% and 25% respectively. Eighty percent of patients reported some barriers to receiving any of the previous vaccines. The three main reasons for not receiving a vaccine were the lack of recommendation, the lack of availability, and the belief that vaccines do not work. Conclusions: The implementation of a pilot vaccination QI program led by rheumatology fellows-in-training showed promising preliminary benefits in the vaccination uptake among RD patients and helps to evaluate the barriers to surpass.

Tipo de elemento:

Article

Palabras claves no controlados:

Enfermedades reumáticas; Mejora de la calidad; Vacunación; Adopción de vacunas.

Materias:

R Medicina > RC Medicina Interna, Psiquiatría, Neurología

Divisiones:

Medicina

Usuario depositante:

Editor Repositorio

Creadores:

Creador	Email	ORCID
Figueroa Parra, Gabriel	gabriel.figueroapr@uanl.edu.mx	orcid.org/0000-0002-6077-8899
Moreno Salinas, Andrea	NO ESPECIFICADO	orcid.org/0000-0002-5321-8922
Santoyo Fexas, Leticia	NO ESPECIFICADO	orcid.org/0000-0003-3095-7666
Gamboa Alonso, Carmen Magdalena	magdis_gam@hotmail.com	orcid.org/0000-0002-6879-0884
Carrizales Luna, Juan Pablo	NO ESPECIFICADO	orcid.org/0000-0002-5903-0007
Hernández Galarza, Ivan de Jesús	NO ESPECIFICADO	orcid.org/0000-0001-9597-8789
Galarza Delgado, Dionicio Ángel	dgalarza@medicinauanl.mx	orcid.org/0000-0001-9714-2109
Esquivel Valerio, Jorge Antonio	jorge.esquivelvl@uanl.edu.mx	orcid.org/0000-0002-3124-0395